← All trials
NCT06854029
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Nov 30, 2025
- Primary completion
- Dec 31, 2029
- Completion date
- Jun 30, 2030
- First posted
- Mar 3, 2025
- Last posted
- Mar 3, 2025
- Enrollment
- 300
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Duke UniversityLead sponsor
- Brown UniversityCollaborator
- University of ArkansasCollaborator
- Friends Research Institute, Inc.Collaborator
- National Institute on Drug Abuse (NIDA)Collaborator
- Duke UniversityOfficial
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.